Jörg has a background in veterinary medicine and a doctorate in Animal Physiology. He has over 20 years’ experience in various cross-functional and multi-national leadership positions in R&D both for Human Prescription Medicines as well as Animal Health. Over more than 10 years he gained experience as an International Project Leader in different organizations in Europe and the US both in developing medicinal products as well as in organizational and strategic projects. Over the past 6 years Jörg was leading the Global Pharmaceutical R&D and International Project Management organization within Boehringer Ingelheim Animal Health. In this function he was responsible for the development of innovative pharmaceutical products for Companion Animals and Life Stock as well as for quality of the pharmaceutical pipeline. Following the acquisition of Merial from Sanofi effective January 2017, Boehringer Ingelheim Animal Health became the 2nd largest animal health company in the world. In his new role as Global Integration Lead R&D Jörg is leading an international and cross-functional team with the aim to integrate the heritage R&D organizations of Merial and BI Animal Health into a new best in the industry organization for research and development of innovative vaccines, pharmaceuticals and diagnostics for prevention and treatment of diseases in livestock and companion animals.